Le Lézard
Classified in: Health, Business
Subjects: CON, LIC

Leading Blockchain-based Healthtech Platform, Aenco, Joins Enterprise Ethereum Alliance


SINGAPORE, July 18, 2018 /PRNewswire/ -- Aenco, the world's first Blockchain-based healthtech digital financing solutions provider, has announced a major milestone in their project as they officially join Enterprise Ethereum Alliance (EEA) today. The membership of the renowned Ethereum standards platform which has top Fortune-500 companies on board is expected to provide a vital boost to Aenco's current partnership network and further build up of its ecosystem.

Speaking about the milestone, Aenco's spokesperson said the decision is "a proof of the company's commitment to delivering project promises within the framework of the best enterprise features and requirements of the Ethereum ecosystem as provided by EEA". The bigger implication of this membership is that Aenco now has access to the world-class services available on the EEA platform. Notably, these services or resources available at EEA include best practices in governance models and accountability, clarity around IP and licensing models for open source technology as well as access to resources for leveraging Ethereum Blockchain technology to address specific industry use cases.

By becoming a member of the EEA, Aenco has taken a big step towards providing a stronger capacity drive across its value chain, particularly in delivering the promises of key services in supporting a robust healthtech ecosystem. Aenco will focus on the following products:

The synergy between these two companies is expected to further expand the benefits of the revolutionary Blockchain technology to the healthtech industry of Aenco is at the forefront. Already, Aenco has positioned themselves to be industry leaders with their trailblazing value proposition to the healthcare technology sector via the smart solutions listed above as well as their overall growing ecosystem utility.

Getting on the EEA platform, also helps Aenco capitalize on the leverage of an atmosphere of regulated entities to supply Blockchain-based financial solutions that effectively tackle challenges facing the industry. These challenges include lack of a robust financial ecosystem for healthtech innovations, high entry barriers and burdensome hurdles in fundraising, little or no options for start-ups requiring end-to-end digital capital solutions and lack of a credible, global-accredited standard for token sale best practices across relevant jurisdictions.

Aenco's membership of EEA sets the stage for them to fully transform the healthcare technology sector through Blockchain's disruptive power. They can now focus on creating the enabling environment that will drive deep impact solutions, such as treatment and prevention of diseases as well as democratize entrepreneurialism in the sector through their Aenco community ecosystem.

About Aenco Solutions Limited
Aenco consists of a team with strong corporate management experience from global investment banks and financial institutions, as well as blockchain technologists and enthusiasts. Aenco is the world's first blockchain-based healthcare technology financial solutions platform, connecting its ecosystem with the wider healthcare technology community.

Website: https://www.Aencoin.com
Telegram: https://t.me/Aenco 
LinkedIn: https://www.linkedin.com/company/Aenco 
Medium: https://medium.com/@Aencoin 
Twitter: https://twitter.com/Aencoin 
Facebook: www.facebook.com/Aencoin 
Discord: https://discord.gg/5nTn4rC 
YouTube: YouTube.Aencoin.com 

 


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: